Global Pharmaceutical & Biotechnology Outlook 2014: Major US and EU

Published: January 2014
No. of Pages: 113
    ReportsandReports

This report is available at 15% Discount till 31st Jan 2017. To avail discount please contact at +1-888-391-5441 / sales@reportsandreports.com.


Strategy Diversification Divested: Productivity measurements, Divestment of non-core assets resulting in healthy Cash position- Will accelerate Next wave of targeted acquisition

In the recent years several new therapies have been approved in the area of diabetes (SGLT-2, GLP-1 agonists), Multiple Sclerosis, HCV, melanoma and breast cancer from major pharmaceutical companies. Many of them are expected to reach multibillion dollars peak sales in the near-term which is likely to compensate the patent expiry loss in top-line revenue. Novel mechanisms like anti-PD1, anti-PCSK9 and CDK inhibitors have also got exclusive attention by large cap Pharma companies. Most companies are in race to acquire assets in these hot therapy areas. Companies who already have these assets are investing heavily in clinical development programs. The interest in pursuing opportunities in Oncology therapy is unhindered for all major Pharma companies.  Research investments in oncology likely to continue for several more years due to the significant unmet need exist in this area.

But for a few companies, patent expiry impact continues to haunt the top-line and they are finding it difficult to replace declining sales with Proprietary pipeline products. Beyond 2013, the impact of patent loss will further aggravate the revenue decline.  They have chosen strategies of prioritization pipeline assets, cost efficiency measures, divestment of non-core assets which yield poor margins and increase focus on therapy areas where they have already proven its mettle. Increase in dividend payout and share repurchase are some near term measures where they are actively participating. Gain in financial strength through divestment of non-core assets (OTC, Animal Health, Consumer health, Diagnostics) will be utilized in pursuing opportunities in high margin therapy areas. At the same time it has becoming more difficult to find such lucrative assets because they are scarce and if available are trading at very high premium in speculation of getting acquired (ex. Roche-Alexion). Going forward, Economies of Scale will also play a major role in swapping the non-core business among major pharma including Vaccines, OTC and animal health to improve margins.

Global Pharma continues to remain attractive due to management efforts on the restructuring of entire business model, cost efficiency measures, de-consolidation, acquisition of high value targeted assets, share repurchase program and dividend policy.

Global Biopharmaceutical Outlook 2014-Global Pharma, released by MP Advisors provides analyses of individual large cap companies, promising drug candidates in their late stage pipelines, competitive landscape, and important therapy areas where new innovation will create leadership, forecast for major marketed drugs where competition/ regulatory scenario will change the dynamics, and the potential impact of several important upcoming milestones on the industry

Published By: MP Advisors
Product Code: MP Advisors14


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:

  • Europe Glimepiride Market Report 2016

    Notes: Sales, means the sales volume of Glimepiride Revenue, means the sales value of Glimepiride This report studies sales (consumption) of Glimepiride in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focus...

  • Europe Dolutegravir Market Report 2016

    Notes: Sales, means the sales volume of Dolutegravir Revenue, means the sales value of Dolutegravir This report studies sales (consumption) of Dolutegravir in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, fo...

  • Global Penicillin Market Professional Survey Report 2016

    Notes: Production, means the output of Penicillin Revenue, means the sales value of Penicillin This report studies Penicillin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue...

  • Global Letrozole Market Professional Survey Report 2016

    Notes: Production, means the output of Letrozole Revenue, means the sales value of Letrozole This report studies Letrozole in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, c...

  • United States Sea Cucumber Capsule Market Report 2016

    Notes: Sales, means the sales volume of Sea Cucumber Capsule Revenue, means the sales value of Sea Cucumber Capsule This report studies sales (consumption) of Sea Cucumber Capsule in United States market, focuses on the top players, with sales, ...

  • Global Indomethacin Market Professional Survey Report 2016

    Notes: Production, means the output of Indomethacin Revenue, means the sales value of Indomethacin This report studies Indomethacin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, r...

  • United States Veterinary Drugs Market Report 2016

    Notes: Sales, means the sales volume of Veterinary Drugs Revenue, means the sales value of Veterinary Drugs This report studies sales (consumption) of Veterinary Drugs in United States market, focuses on the top players, with sales, price, reven...

  • United States, EU, Japan, China, India and Southeast Asia Tuberculosis Testing Market Size, Status and Forecast 2021

    Notes: Production, means the output of Tuberculosis Testing Revenue, means the sales value of Tuberculosis Testing This report studies the global Tuberculosis Testing market, analyzes and researches the Tuberculosis Testing development status an...

  • United States Alopecia Drugs Market Report 2016

    Notes: Sales, means the sales volume of Alopecia Drugs Revenue, means the sales value of Alopecia Drugs This report studies sales (consumption) of Alopecia Drugs in United States market, focuses on the top players, with sales, price, revenue and...

  • Europe Intravenous Solution Market Report 2016

    Notes: Sales, means the sales volume of Intravenous Solution Revenue, means the sales value of Intravenous Solution This report studies sales (consumption) of Intravenous Solution in Europe market, especially in Germany, UK, France, Russia, Ital...


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: